Search - tctmd.com

Displaying 241 - 260 of 307

Sort: Relevancy | Date

News Daily News

ACS患者的中度/重度钙化会导致PCI后结果恶化

Yael L. Maxwell

February 20, 2014

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Daily News

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

Caitlin E. Cox

November 01, 2013

Presentation

Early Short-term Doxycycline Therapy in Patients with AMI and LV Dysfunction

Presenter: Giampaolo Cerisano

October 14, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

远端保护在早期有益于STEMI的血栓切除治疗，但是并无长期受益

L.A. McKeown

September 27, 2013

News Daily News

El Recuento Basal de Glóbulos Blancos Predice el Tamaño del Infarto en los STEMI Anteriores

Yael L. Maxwell

September 27, 2013

News Daily News

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

L.A. McKeown

September 27, 2013

News Daily News

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Yael L. Maxwell

September 27, 2013

Presentation

Impact of Intracoronary Bone Marrow Cell Therapy on LV Function in the Setting of STEMI

Presenter: Ronak Delewi

September 16, 2013

News Conference News ESC 2013

PROMISE: Intracoronary Adenosine Effective in STEMI Patients with Shorter Ischemic Times

September 03, 2013

News Daily News

Un Fármaco Reductor de la Frecuencia Cardíaca resulta Prometedor para Pacientes STEMI tras PCI

L.A. McKeown

July 19, 2013

News Daily News

Heart Rate-Lowering Drug Shows Promise for STEMI Patients After PCI

L.A. McKeown

July 19, 2013

News Daily News

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

Leah Lawrence

July 11, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Daily News

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

Jason Kahn

June 28, 2013

News Daily News

Las Células Madre de la Médula Ósea No son Efectivas Antes ni Después de sufrir un IAM

Jason Kahn

April 26, 2013

News Daily News

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Jason Kahn

April 26, 2013

News Daily News

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

February 27, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

Advertisement

ACS患者的中度/重度钙化会导致PCI后结果恶化

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

Early Short-term Doxycycline Therapy in Patients with AMI and LV Dysfunction

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

远端保护在早期有益于STEMI的血栓切除治疗，但是并无长期受益

El Recuento Basal de Glóbulos Blancos Predice el Tamaño del Infarto en los STEMI Anteriores

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Impact of Intracoronary Bone Marrow Cell Therapy on LV Function in the Setting of STEMI

PROMISE: Intracoronary Adenosine Effective in STEMI Patients with Shorter Ischemic Times

Un Fármaco Reductor de la Frecuencia Cardíaca resulta Prometedor para Pacientes STEMI tras PCI

Heart Rate-Lowering Drug Shows Promise for STEMI Patients After PCI

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

Las Células Madre de la Médula Ósea No son Efectivas Antes ni Después de sufrir un IAM

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content